An intervention demonstrates metabolic health improvement in CKD by reducing stress response related to low-protein diets.
Although low-protein diet (LPD) slows CKD progression, its metabolic mechanisms remain unclear. Given adherence challenges and PEW risk, this study examined whether LPD improves metabolic health through uremic toxin (UT) reduction, improved glucose metabolism, and microbiota changes, focusing on fibroblast growth factor 21 (FGF21), a liver hormone that responds to protein restriction by promoting food intake and increasing energy expenditure in both CKD mice and humans. It also tested whether Lactiplantibacillus plantarum (LpWJL)—identified for growth promotion under nutrient restriction—could alleviate LPD-induced metabolic stress and PEW by modulating amino acid levels and FGF21 in CKD mice.
No takes yet. Share an insight, caveat, or question.
Benoit et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: